Literature DB >> 27496102

Chilo iridescent virus (CIV) ORF 012L encodes a protein with both exonuclease and endonuclease functions.

Yesim Akturk Dizman1,2, Hacer Muratoglu3, Cemal Sandalli2, Remziye Nalcacioglu4, Zihni Demirbag1.   

Abstract

Chilo iridescent virus (CIV) is the type member of the genus Iridovirus within the family Iridoviridae. The virions of CIV contain a single linear dsDNA molecule that is circularly permuted and terminally redundant. The genome of CIV contains an open reading frame (ORF 012L) encoding a protein homologous to exonuclease II of Schizosaccharomyces pombe. In this study, we focused on the characterization of CIV ORF 012L. The target ORF was cloned into the pET28a vector, expressed in E. coli strain BL21 (DE3) pLysS with an N-terminal His tag and purified to homogeneity by using Ni-NTA affinity chromatography. Biochemical characterization of the purified CIV 012L confirmed that this viral protein is a functional 5'-3' exonuclease that digests 3'-biotin-labelled oligonucleotides and linear double-stranded DNA (dsDNA) molecules from their 5' termini in a highly processive manner. CIV 012L also has a potent endonuclease activity on dsDNA in vitro. In addition, CIV 012L converted supercoiled plasmid DNA (replicative form I, RFI) into the open circular form (RFII) and then open circular form into linear form (RFIII). Endonuclease activity of CIV 012L was optimal in the presence of 10 mM Mg(2+) or 30 mM Mn(2+) ions and at 150 mM NaCl or KCl salt concentrations. The highest endonuclease activity was obtained at pH 8, and it reached a maximum at 55 °C. The CIV 012L protein showed deficiencies for both double- and single-stranded RNAs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27496102     DOI: 10.1007/s00705-016-3007-4

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  1 in total

1.  A haplotype in CFH family genes confers high risk of rare glomerular nephropathies.

Authors:  Yin Ding; Weiwei Zhao; Tao Zhang; Hao Qiang; Jianping Lu; Xin Su; Shuzhen Wen; Feng Xu; Mingchao Zhang; Haitao Zhang; Caihong Zeng; Zhihong Liu; Huimei Chen
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.